BRIEF published on 04/25/2024 at 16:05, 2 years ago AlayaCare and Corus Health Partner to Revolutionize Home Care in New Mexico Healthcare Technology AlayaCare Home Care Patient-Centered Care Corus Health
BRIEF published on 04/25/2024 at 16:05, 2 years ago AlayaCare et Corus Health s'associent pour révolutionner les soins à domicile au Nouveau-Mexique AlayaCare Soins À Domicile Technologie De La Santé Soins Centrés Sur Le Patient Corus Santé
BRIEF published on 04/25/2024 at 16:04, 2 years ago Schoeller-Bleckmann Announces Dividend for Fiscal Year 2023 Dividend 2023 Fiscal Year Vienna Stock Exchange Schoeller-Bleckmann Capital Gains Tax
BRIEF published on 04/25/2024 at 16:04, 2 years ago Schoeller-Bleckmann annonce un dividende pour l'exercice 2023 Exercice 2023 Dividende Schoeller-Bleckmann Impôt Sur Les Plus-values Bourse De Vienne
BRIEF published on 04/25/2024 at 15:50, 2 years ago Modification du calendrier financier de WEB SA pour 2023 Calendrier Financier Assemblée Générale Rapport Annuel WEB SA Dividende 2023
BRIEF published on 04/25/2024 at 15:50, 2 years ago Modification of WEB SA's financial calendar for 2023 Financial Calendar Annual Report General Assembly WEB SA Dividend 2023
BRIEF published on 04/25/2024 at 15:50, 2 years ago ALKEME Acquires Ralph Weiner & Associates to Boost Midwest Presence Strategic Partnership ALKEME Acquisition Ralph Weiner & Associates Insurance Expansion Midwest Market
BRIEF published on 04/25/2024 at 15:50, 2 years ago ALKEME acquiert Ralph Weiner & Associates pour renforcer sa présence dans le Midwest Partenariat Stratégique Acquisition D'ALKÉME Ralph Weiner & Associés Extension De L'assurance Marché Du Midwest
BRIEF published on 04/25/2024 at 15:50, 2 years ago Moleculin Biotech Emphasizes Annamycin's Role in AML Treatment in JTC Virtual Investor Segment Clinical Trials Investment Opportunity Moleculin Biotech Annamycin AML Treatment
BRIEF published on 04/25/2024 at 15:50, 2 years ago Moleculin Biotech souligne le rôle de l'annamycine dans le traitement de la LMA dans le segment des investisseurs virtuels du JTC Essais Cliniques Opportunité D'investissement Biotechnologie Moléculaire Annamycine Traitement LMA
Published on 05/02/2026 at 21:00, 3 hours 26 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 22 hours 56 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 23 hours 36 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/02/2026 at 15:35, 8 hours 50 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 1 day 6 hours ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 04/30/2026 at 21:21, 2 days 3 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 2 days 4 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 2 days 4 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 2 days 5 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 2 days 5 hours ago AXA annonce les résultats de son Assemblée Générale
